The peripheral nervous system has complex and intricate ramifications throughout many target organ systems. To date this system has not been effectively labeled by genetic markers, due largely to inadequate transcriptional specification by minimum promoter constructs. Here we describe transgenic mice in which enhanced green fluorescent protein (eGFP) is expressed under the control of endogenous choline acetyltransferase 
Introduction
Studies of the development and adaptation of the nervous system have been facilitated by the generation of transgenic mice in which specific neuronal populations express marker proteins such as lacZ or fluorescent proteins (4, 8, 10, 17, 27) . The expression of such proteins in sympathetic and parasympathetic nerves would be particularly advantageous for the in vivo study of these widely distributed and poorly understood nervous systems. However, the use of minimal promoter elements derived from parasympathetic or adrenergic genes such as choline acetyltransferase (ChAT) or dopamine hydroxylase have not provided robust and comprehensive identification of peripheral nerves when used to direct the expression of transgenes in the mouse (16, 17, 19, 20) .
The "cholinergic locus" consists of the choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) genes, the latter gene entirely contained within the first intron of the former (11, 21) . Because ChAT is essential for acetylcholine biosynthesis, several groups have used 5' flanking DNA from this region to direct transgene expression in selective cholinergic neuron populations (16, 19, 20) . While demonstrating expression confined to cholinergic neurons, these constructs do not provide robust peripheral expression. This lack of expression is probably due to the complex nature of ChAT and VAChT regulatory elements, which include enhancer and suppressor elements and significant tissue -specific splicing (14, 18) . Thus, for example, Misawa and colleagues recently reported the development of a mouse expressing Cre recombinase and eGFP under control of a 11.3 kb fragment of the cholinergic locus, placing the GFP-IRES-Cre within the VAChT coding region (19) ; no expression was Page 4 of 36 5 observed in parasympathetic nerves in these mice. A bacterial artificial chromosome (BAC) transgenic approach utilizing the ChAT locus to direct expression of eGFP has been described (10). However, marker expression in peripheral cholinergic neurons was not reported in these mice, preventing determination of the effectiveness of the BAC strategy employed.
We reasoned that endogenous regulatory elements associated with the ChAT locus should effectively specify transgene expression in central and peripheral neurons, as well as other cells that synthesize acetylcholine, and employed a BAC transgenic approach to preserve these elements. Here we report that transgenic mice using a ChAT locus -spanning BAC, in which eGFP is knocked into exon 3 at the ChAT initiation codon, robustly and selectively express eGFP in all cholinergic nerves of the central and peripheral nervous systems (CNS and PNS), as well as in non-neuronal cells.
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Materials and Methods
Generation of Tg(RP23-268L19-eGFP)Kot
The BAC clone RP23-268L19, containing ~78 kb and ~36 kb of DNA flanking the 5' and 3' ends of the ChAT locus, respectively, was obtained from the BAC resource at Children's Hospital Oakland Research Institute. The eGFP cassette was inserted at the initiation codon of the ChAT coding sequence, which is located within exon 3, by homologous recombination using a targeting vector designed for BAC recombineering (13, 15, 31) . ChAT homologous arms were amplified and inserted upstream and downstream of the eGFP sequence in plasmid pBS-eGFP-FRT-Neo/Kan-FRT (Kotlikoff laboratory); ChAT arm1 was a 596 bp fragment upstream of the ATG in exon 3 and was created using forward and reverse primers: 5'-GGC CTT AGA ATA CTT GTG GG-3' and 5'-CCT AGC GAT TCT TAA TCC A-3'. An XhoI site was added to the 5' end of the forward primer and a SmaI site was added to the 5' end of the reverse primer. ChAT arm2 was a 588 bp product downstream of the ATG codon of exon 3 using the forward primer 5'-CCT ATC CTG GAA AAG GTC-3', with a SpeI site added to the 5'end, and the reverse primer 5'-GAG AAC AAT CAT CCA GAC CA-3' with a SacI site added to the 5' end. Plasmid pBS-eGFP-FRT-Neo/Kan-FRT was cut with XhoI and SmaI and ChAT arm1 inserted followed by SpeI and SacI digestion and insertion of ChAT arm2.
ChAT(arm1)-eGFP-FRT-Neo/Kan-FRT-ChAT(arm2) cassette was released from the plasmid by XhoI and SacI digestion. The RP23-268L19 BAC was electroporated into the recombinogenic E. coli strain EL250 and positive colonies selected with chloramphenical. EL250 cells carrying RP23-268L19 BAC were electroporated with ChAT(arm1)-eGFP-FRT-Neo/Kan-FRT-ChAT(arm2) and homologous recombined Following confirmation of homologous recombination by PCR and sequencing the BAC using primers that flanked the upstream of ChAT arm1 to eGFP cassette and downstream of ChAT arm2 to eGFP cassette the ChAT BAC -eGFP DNA was prepared using a modified alkaline lysis protocol (QIAGEN kit). Circular intact ChAT BAC -eGFP DNA was microinjected into fertilized embryos using standard pronuclear injection techniques.
Toe genomic DNA was purified using Puragene (Gentra Systems, Minnesota) and founder mice carrying the BAC transgene were identified by PCR with primer sets RP23- 
In Vivo and Ex Vivo Imaging
In vivo and ex vivo images were obtained using a Lieca MZFLIII stereomicroscope or OV100 macro imaging system (Olympus) with bandpass eGFP filter cubes and fluorescent images captured using a DP70 camera (Olympus). Reconstruction of some images was accomplished using ImageJ (National Institute of Health free software) extended depth of focus plug-in. The acquisition of multiphoton images has previously been described (32) .
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Results
Generation of ChAT
BAC -eGFP mouse
Two ChAT BAC -eGFP founder lines, ChAT line 2 and ChAT line 44, were generated by replacing the initial codon of ChAT gene contained in exon 3 with the entire eGFP sequence followed by a polyadenylation signal sequence, thus placing eGFP under control of the endogenous regulatory elements contained in the cholinergic gene locus ( Figure 1A ) (5). Mice were identified by either a 620 bp or 505 bp PCR product, using primers specific for either the BAC vector or the sequence between ChAT and eGFP ( Figure 1A ). The offspring appeared grossly normal and the transgene was transmitted in a normal Mendelian inheritance pattern. We systemically evaluated both founder lines for eGFP specificity and expression using fluorescent imaging and immunohistochemistry and no apparent differences were observed between the two 
Expression of eGFP in cholinergic nerves of the central nervous system
We analyzed the cholinergic CNS regions expressing eGFP and cell specificity of the fluorescence in our mice. Whole brain mounts from adult ChAT To document the cholinergic specific expression of eGFP at the cellular level, we performed immunohistochemistry using antibodies against ChAT and eGFP in sequential brain slices. Anti-eGFP immunostaining was more prominent in cell bodies and neuronal processes when compared to anti-ChAT immunostaining ( Figure 2F ). Comparison of the same regions in serial sections indicated that eGFP and ChAT were expressed in the same neuronal cell populations throughout the brain except in two regions: olfactory cortex and 12 amygdaloid. To our surprise anti-ChAT did not stain these two areas even though reports by other groups and our ChAT BAC -eGFP mice expressed eGFP in these regions; this is most likely attributable to differences in immunohistochemistry techniques (20, 22) . In double labeling experiments, eGFP -expressing neurons were co-labeled by antibodies directed against neuronal nitric oxide (nNOS), a neuron specific synthatase, or synaptophysin, an integral membrane protein expressed in the presynaptic vesicle in neurons (not shown). Moreover, an astrocyte -specific antibody directed against glial fibrillary acidic protein, did not label eGFP -positive cells in brain slices (not shown).
Taken together these data demonstrate that ChAT BAC -eGFP mice express eGFP in cholinergic cell bodies and processes of the CNS, including elements specific to the autonomic nervous system.
Expression of eGFP in cholinergic nerves of the peripheral nervous system
We next evaluated eGFP fluorescence in elements of the PNS in both in vivo and ex vivo preparations, to determine the extent to which eGFP is expressed in ChAT BAC -eGFP mice cell bodies and extensive processes of cholinergic nerves, including motor neuron axons and pre and post -synaptic autonomic neurons. As shown in Figure 3A , adult mice display robust eGFP fluorescence on the lateral surface of the jaw in all branches of the facial nerve, which carries motor axons from cell bodies in cranial nerve VII to facial muscles. Fluorescence extended through nerve branches to the neuromuscular junction ( Figure 3B ), indicating efficient axonal transport of transgene protein and/or mRNA. Superficial motor neurons running along the lateral and medial surfaces of the thoracic and pelvic limbs also expressed eGFP (data not shown).
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Similarly, phrenic motor nerves projecting to the diaphragm from cervical nerves 3-5 displayed intense in vivo fluorescence ( Figure 3C ). These data indicate effective marking of postganglionic motor neurons of the somatic peripheral nervous system.
Of perhaps more significance, eGFP was observed in the parasympathetic nervous system, which has not been effectively labeled by transgenic methods (16, 20) . As shown in Figure 3C , the vagus nerve trunk displayed clear fluorescence within the thoracic cavity, although the fluorescence intensity of the vagus both in the neck and thoracic cavity was distinctly lower than observed in somatic motor nerves. This likely reflects the smaller diameter preganglionic autonomic axons and lower axon density of the nerves, although lower promoter strength in vagal preganglionic neurons could not be excluded.
eGFP expression was also observed in ganglionic neurons; three different ganglia, representing predominately parasympathetic, sympathetic, or mixed neurons (6, 28) , were evaluated. The parasympathetic ciliary ganglion located on the dorsal surface of the eye receives preganglionic fibers from the Oculomotor nerve (III) and synapses on postganglionic fibers projecting to smooth muscle of the eye (6); eGFP was expressed in the preganglionic Oculomotor nerve running parallel with the optic nerve, the preganglionic Oculomoter nerve at the ciliary ganglion, and postganglionic cell bodies and ciliary nerve fibers ( Figure 3E ). The second ganglia we assessed was the paravertebral chain ganglia containing sympathetic preganglionic nerves that exit the ventral root of the thoracic and lumber spine to form synapses on postganglionic cell bodies. As shown in Figure 3F , paravertebral ganglia display eGFP fluorescence in processes running to, and synapsing within, the ganglia. Finally, we evaluated mixed Page 13 of 36 sympathetic and parasympathetic neurons within the pelvic ganglia located on the dorsal surface of the prostate gland. These ganglia receive inputs from lumbar and sacral regions of the spinal cord and are the major autonomic ganglia supplying postganglionic nerves to reproductive organs, the lower urinary tract, and the lower bowel (28) . As shown in Figure 3G , the major nerves of the pelvic ganglia were easily distinguished by eGFP fluorescence in ChAT BAC -eGFP mice (28) .
Postganglionic, parasympathetic process innervating target organs also display strong eGFP fluorescence, an important advantage of ChAT BAC -eGFP mice for physiological studies. As shown in Figure 3H , postganglionic fibers were labeled in a variety of target organs, including within the extensive submucosal plexus of the gastrointestinal tract. Single non-neuronal epithelial cells were also labeled within the gastrointestinal mucosa (also see below). The sweat gland is unusual in that sympathetic innervation switches during development from catecholaminergic to cholinergic; Figure   3I demonstrates that eGFP fluorescence is observed in hind foot sweat glands in adult ChAT BAC -eGFP mice, demonstrating that this transition has occurred (26) . Taken together, these data demonstrate the ability to visualize postganglionic projections of the somatic motor, sympathetic and parasympathetic PNS in vivo and ex vivo.
Cellular Expression of eGFP in the PNS
To more carefully examine the cellular pattern and neuronal specific nature of ChAT driven eGFP expression in target tissues we performed immunostaining using anti-GFP antibodies. As shown in Figure 4A , eGFP was detected in the cytoplasm of cell bodies present within ganglia and processes of nerves similar to earlier findings (12) . To Meissner's plexus co-labeled with eGFP and nNOS, a ratio similar to previous reports in the mouse (data not shown) (24) . Choline acetyltransferase has also been reported to be present in non-neuronal cells within lung and intestine (29) . Prominent eGFP immunostaining was observed in non-neuronal tissues in ChAT BAC -eGFP mice ( Figure   4B ), consistent with the observation of intense focal fluorescence in these tissues ( Figure   3H ). To identify the cell populations in the lung and intestine expressing eGFP, we used specific markers for epithelial cells (keratin), neuroendocrine cells (synaptophysin),
lymphocytes (CD38), macrophages (MAC387), and goblet cells (Ascian blue and
Periodic Acid Shift). eGFP colocalized with keratin and a subpopulation of lymphocytes but not with neuroendocrine or goblet cell markers, consistent with the expression of the transgene in epithelial cells and T lymphocytes (data not shown) (29) .
Embryonic Development
The high degree of fidelity of eGFP expression in cholinergic cells conferred by the BAC transgene provides an effective way to study the development and adaptation of cholinergic neurons, including the targeting of motor neurons to specific muscles and the complex ramifications of the parasympathetic nervous system. To confirm the early embryonic expression of eGFP we examined ChAT 10.5 dpc, cranial ganglia displayed robust eGFP fluorescence, the eGFP fluorescence between the somites was identified in a cross-section taken below the level of the heart as ventral motor neurons. In addition, sympathetic ganglion and enteric neurons were identified in this cross-section ( Figure 5A-C) . By 13.5 dpc eGFP fluorescence was prominent between the digits of both fore-and hind limbs ( Figure 5D and E) . Figure 5F shows a cross-section taken at the brachial level with cholinergic dependent eGFP fluorescence in the bilateral ventral roots, bilateral sympathetic ganglia, left vagal sympathetic trunk and fine projections to the limbs. At this stage fluorescent nerve projections to the gastrointestinal organs were apparent including significant ramifications within the smooth muscle and mucosal layers, which became progressively more extensive by 16.5 dpc and 18.5 dpc, consistent with previous literature ( Figure 5G ) (7).
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Discussion
The peripheral nervous system is an extensive, diverse, and highly adaptive system that plays essential roles both as the conduit for central control of higher order function, and as a distributed nervous system capable of complex pattern generation and processing in local ganglia. The extensive ramifications, complex wiring, and diverse expression of neurotransmitters, particularly in the autonomic nervous system, have complicated neurophysiological evaluation of the PNS. Recently, substantial progress has been made in the understanding of complex central processing through the use of genetic approaches that enable the targeting of specific neuronal populations and also provide a mechanism to regulate gene expression in these cells. Here we report specific and effective labeling of the cholinergic nervous system using BAC transgenic methods that exploit the ChAT gene locus. The ChAT gene resides in a complex "cholinergic locus" with numerous poorly understood tissue specific regulatory elements and a second gene, VAChT, contained within the first intron (11, 20) (1, 23) . Despite the likely lower copy number of large BAC inserts, eGFP expression was found to be remarkably high, and excellent axonal transport was achieved without fusion of the tau microtubule binding protein (23) . We have observed this phenomenon in several BAC transgenics and attribute the strong expression to the fact that the large genomic provides the complete regulatory context required for robust gene expression. Finally, as previously noted, the BAC approach requires little or no knowledge of the underlying gene regulatory elements and is amenable to both relatively high throughput approaches (10). The specific strategy used here should be an effective way to obtain lineage specific transgene expression that extends to cholinergic nerves within the autonomic nervous system, such as the expression of Cre recombinase or specific neural factors. 
